{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:02:34Z","timestamp":1780635754639,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.npep.2025.102568","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:13:21Z","timestamp":1761959601000},"page":"102568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pituitary adenylate cyclase-activating polypeptide (PACAP) attenuates diabetic cardiomyopathy via Nrf2\/HO-1 antioxidant signaling and NF-\u03baB-mediated inflammation suppression in streptozotocin-treated mice"],"prefix":"10.1016","volume":"114","author":[{"given":"Dong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huozhao","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liancai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2025.102568_bb0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.peptides.2013.02.002","article-title":"Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy","volume":"42","author":"Banki","year":"2013","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.npep.2025.102568_bb0010","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/CIRCRESAHA.118.310082","article-title":"Calcium Signaling and reactive oxygen species in mitochondria","volume":"122","author":"Bertero","year":"2018","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.npep.2025.102568_bb0015","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"issue":"9\u201310","key":"10.1016\/j.npep.2025.102568_bb0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"Dis. Model. Mech."},{"issue":"2","key":"10.1016\/j.npep.2025.102568_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","article-title":"Nrf2 at the heart of oxidative stress and cardiac protection","volume":"50","author":"Chen","year":"2018","journal-title":"Physiol. Genomics"},{"issue":"1","key":"10.1016\/j.npep.2025.102568_bb0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.npep.2025.102568_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.freeradbiomed.2015.04.028","article-title":"Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110\u03b1) signaling","volume":"87","author":"De Blasio","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"45","key":"10.1016\/j.npep.2025.102568_bb0040","doi-asserted-by":"crossref","first-page":"31930","DOI":"10.1074\/jbc.274.45.31930","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation","volume":"274","author":"Delgado","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.npep.2025.102568_bb0045","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4049\/jimmunol.167.2.966","article-title":"Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo","volume":"167","author":"Delgado","year":"2001","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.npep.2025.102568_bb0050","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.npep.2025.102568_bb0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1358\/dnp.2005.18.6.927930","article-title":"Cardioprotective role of the VIP signaling system","volume":"18","author":"Dvor\u00e1kov\u00e1","year":"2005","journal-title":"Drug News Perspect"},{"issue":"4","key":"10.1016\/j.npep.2025.102568_bb0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","article-title":"Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"25","author":"Fang","year":"2004","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.npep.2025.102568_bb0065","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.npep.2025.102568_bb0070","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/ars.2015.6293","article-title":"Mitochondrial dynamics in diabetic cardiomyopathy","volume":"22","author":"Galloway","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.npep.2025.102568_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.peptides.2005.06.022","article-title":"Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis","volume":"27","author":"Gasz","year":"2006","journal-title":"Peptides"},{"issue":"9","key":"10.1016\/j.npep.2025.102568_bb0080","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.npep.2025.102568_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fcvm.2020.00012","article-title":"Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy","volume":"7","author":"Kaludercic","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.npep.2025.102568_bb0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/antiox11030559","article-title":"Role and potential mechanism of Heme Oxygenase-1 in intestinal ischemia-reperfusion injury","volume":"11","author":"Katada","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.npep.2025.102568_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.694864","article-title":"Mechanisms and therapeutic prospects of diabetic cardiomyopathy through the inflammatory response","volume":"12","author":"Kaur","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.npep.2025.102568_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/216512","article-title":"Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy","volume":"2012","author":"Li","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.npep.2025.102568_bb0105","article-title":"Mitochondrial dynamics and mitophagy in cardiometabolic disease","volume":"9","author":"Lin","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.npep.2025.102568_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.746382","article-title":"Left ventricular hypertrophy in diabetic cardiomyopathy: a target for intervention","volume":"8","author":"Mohan","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.npep.2025.102568_bb0115","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1253\/circj.CJ-09-1024","article-title":"Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on doxorubicin-induced cardiomyopathy in mice","volume":"74","author":"Mori","year":"2010","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.npep.2025.102568_bb0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jacc.2017.05.035","article-title":"Impact of oxidative stress on the heart and vasculature: part 2 of a 3-part series","volume":"70","author":"M\u00fcnzel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.npep.2025.102568_bb0125","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbamcr.2017.03.006","article-title":"Molecular regulation of mitochondrial dynamics in cardiac disease","volume":"1864","author":"Nan","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"20","key":"10.1016\/j.npep.2025.102568_bb0130","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.npep.2025.102568_bb0135","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0196-9781(02)00085-2","article-title":"The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells","volume":"23","author":"Onoue","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2025.102568_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221083530","article-title":"Role of inflammation in diabetic cardiomyopathy","volume":"13","author":"Ramesh","year":"2022","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.npep.2025.102568_bb0145","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12031-012-9762-0","article-title":"PACAP is an endogenous protective factor-insights from PACAP-deficient mice","volume":"48","author":"Reglodi","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.npep.2025.102568_bb0150","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.npep.2025.102568_bb0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0167-0115(93)90426-9","article-title":"Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the cardiovascular system","volume":"47","author":"Suzuki","year":"1993","journal-title":"Regul. Pept."},{"issue":"6","key":"10.1016\/j.npep.2025.102568_bb0160","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3390\/ijms22062883","article-title":"PACAP-38 in acute ST-segment elevation myocardial infarction in humans and pigs: a translational study","volume":"22","author":"Szabo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.npep.2025.102568_bb0165","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol. Res."},{"key":"10.1016\/j.npep.2025.102568_bb0170","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1196\/annals.1317.083","article-title":"Protective effects of PACAP in excitotoxic striatal lesion","volume":"1070","author":"Tam\u00e1s","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.npep.2025.102568_bb0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12933-024-02183-5","article-title":"Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53","volume":"23","author":"Tang","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.npep.2025.102568_bb0180","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20150014","article-title":"Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways","volume":"43","author":"Wardyn","year":"2015","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.npep.2025.102568_bb0185","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/ijms26041668","article-title":"Autophagy in high-fat diet and streptozotocin-induced metabolic cardiomyopathy: mechanisms and therapeutic implications","volume":"26","author":"Zhou","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341792500068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341792500068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:37:48Z","timestamp":1780634268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014341792500068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"alternative-id":["S014341792500068X"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2025.102568","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary adenylate cyclase-activating polypeptide (PACAP) attenuates diabetic cardiomyopathy via Nrf2\/HO-1 antioxidant signaling and NF-\u03baB-mediated inflammation suppression in streptozotocin-treated mice","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2025.102568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102568"}}